XML 18 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Shares
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at the beginning of the period at Dec. 31, 2022 $ 19 $ 888,120 $ 44 $ (492,034) $ 396,149
Balance at the beginning of the period (in shares) at Dec. 31, 2022 69,697,503        
Changes in equity          
Issuance of Class A common shares under incentive award plans   90     90
Issuance of Class A common shares under incentive award plans (in shares) 135,576        
Share-based compensation expense   6,115     6,115
Unrealized gain (loss) on short-term investments and currency translation adjustments     11   11
Net Income (Loss)       (12,270) (12,270)
Balance at the end of the period at Mar. 31, 2023 $ 19 894,325 55 (504,304) 390,095
Balance at the end of the period (in shares) at Mar. 31, 2023 69,833,079        
Balance at the beginning of the period at Dec. 31, 2023 $ 20 916,763 6 (477,950) 438,839
Balance at the beginning of the period (in shares) at Dec. 31, 2023 70,460,617        
Changes in equity          
Issuance of Class A common shares under incentive award plans   3,613     3,613
Issuance of Class A common shares under incentive award plans (in shares) 358,479        
Share-based compensation expense   7,206     7,206
Unrealized gain (loss) on short-term investments and currency translation adjustments     (59)   (59)
Net Income (Loss)       (17,704) (17,704)
Balance at the end of the period at Mar. 31, 2024 $ 20 $ 927,582 $ (53) $ (495,654) $ 431,895
Balance at the end of the period (in shares) at Mar. 31, 2024 70,819,096